[Herpes Simplex Virus Infection in Two Premature Infants - Diagnostic and Therapeutic Management]

Roland Haase1,2, Gregor Seliger3, Jan Baier1

  • 1Abteilung für Neonatologie und Pädiatrische Intensivmedizin, Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Deutschland.

Insights

Neonatal herpes simplex virus (HSV) infections pose significant risks, particularly for premature infants. Early diagnosis and treatment with acyclovir are crucial for managing these severe systemic infections.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Virology

Background:

  • Neonatal herpes simplex virus (HSV) infections are rare but severe, carrying high morbidity and mortality rates, especially when treatment is delayed.
  • Premature infants are especially vulnerable due to immature immune systems.
  • Symptoms of neonatal HSV can mimic other serious conditions like sepsis, complicating diagnosis.

Purpose of the Study:

  • To present two cases of premature infants with systemic HSV infections.
  • To discuss the diagnostic and therapeutic management strategies for neonatal HSV.
  • To highlight the importance of timely intervention in improving outcomes.

Main Methods:

  • Case report of two premature infants diagnosed with systemic HSV infections.
  • Review of diagnostic approaches, including patient history and specific tests.
  • Description of treatment protocols involving intravenous and enteral acyclovir.

Main Results:

  • Both infants presented with systemic HSV infections.
  • Successful treatment was achieved using intravenous acyclovir followed by suppressive enteral therapy.
  • The cases underscore the need for prompt diagnosis and management.

Conclusions:

  • Systemic HSV infections in premature neonates require vigilant diagnosis and prompt treatment.
  • Intravenous and subsequent enteral acyclovir therapy is an effective management strategy.
  • Early intervention is critical to mitigate the high risks associated with neonatal HSV.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
105
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
135
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
206
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
580
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
260
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
70